| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
,§,¶
*
The Center for Blood Research,
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Departments of
Pediatrics,
§
Neurology, and
¶
Pathology, Harvard Medical School, Boston, MA 02115
Low levels of CD2 have been described on subsets of monocytes, macrophages, and dendritic cells. CD2 is expressed on about one-third of circulating monocytes, at levels one-half log lower than on T or NK cells, representing 2–4% of PBMC. FACS analysis of CD2+ and CD2- monocytes revealed no significant difference in the expression of adhesion molecules (CD11a/b/c), class II Ags (HLA-DR, -DQ, -DP), myeloid Ags (CD13, CD14, CD33), or costimulatory molecules (CD80, CD86). Freshly isolated CD2+ and CD2- monocytes were morphologically indistinguishable by phase contrast microscopy. However, scanning electron microscopy revealed large prominent ruffles on CD2+ monocytes in contrast to small knob-like projections on CD2- monocytes. After 2 days of culture, the CD2+ monocytes largely lost CD14 expression and developed distinct dendrites, whereas the CD2- monocytes retained surface CD14 and remained round or oval. Freshly isolated CD2+ monocytes were more potent inducers of the allogeneic MLR and more efficiently induced proliferation of naive T cells in the presence of HIV-1 gp120 than did CD2- monocytes. After culture in the presence of GM/CSF and IL-4, CD2+ monocytes were up to 40-fold more potent than monocyte-derived dendritic cells or CD2- monocytes at inducing allogeneic T cell proliferation. These findings suggest that circulating CD2+ and CD2- monocytes are dendritic cells and the precursors of macrophages, respectively. Thus, dendritic cells are far more abundant in the blood than previously thought, and they and precursors of macrophages exist in the circulation as phenotypically, morphologically, and functionally distinct monocyte populations.
This article has been cited by other articles:
|
|
 |
|
  T. Di Pucchio, L. Pilla, I. Capone, M. Ferrantini, E. Montefiore, F. Urbani, R. Patuzzo, E. Pennacchioli, M. Santinami, A. Cova, et al. Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-{alpha} Results in the Activation of Specific CD8+ T Cells and Monocyte/Dendritic Cell Precursors. Cancer Res., May 1, 2006; 66(9): 4943 - 4951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Narayan, J. L. Chase, R. L. Lewis, X. Tian, D. S. Kaufman, J. A. Thomson, and E. D. Zanjani Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients Blood, March 1, 2006; 107(5): 2180 - 2183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nohara, X. Pan, S.-i. Tsukumo, A. Hida, T. Ito, H. Nagai, K. Inouye, H. Motohashi, M. Yamamoto, Y. Fujii-Kuriyama, et al. Constitutively Active Aryl Hydrocarbon Receptor Expressed Specifically in T-Lineage Cells Causes Thymus Involution and Suppresses the Immunization-Induced Increase in Splenocytes J. Immunol., March 1, 2005; 174(5): 2770 - 2777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Chamian, M. A. Lowes, S.-L. Lin, E. Lee, T. Kikuchi, P. Gilleaudeau, M. Sullivan-Whalen, I. Cardinale, A. Khatcherian, I. Novitskaya, et al. Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris PNAS, February 8, 2005; 102(6): 2075 - 2080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Al-Shangiti, C. E. Naylor, S. P. Nair, D. C. Briggs, B. Henderson, and B. M. Chain Structural Relationships and Cellular Tropism of Staphylococcal Superantigen-Like Proteins Infect. Immun., July 1, 2004; 72(7): 4261 - 4270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. F. Fagnoni, B. Oliviero, G. Giorgiani, P. De Stefano, A. Deho, C. Zibera, N. Gibelli, R. Maccario, G. Da Prada, M. Zecca, et al. Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation Blood, July 1, 2004; 104(1): 281 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Turville, J. Wilkinson, P. Cameron, J. Dable, and A. L. Cunningham The role of dendritic cell C-type lectin receptors in HIV pathogenesis J. Leukoc. Biol., November 1, 2003; 74(5): 710 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Crawford, A. Stark, B. Kitchens, K. Sternheim, V. Pantazopoulos, E. Triantafellow, Z. Wang, B. Vasir, C. E. Larsen, D. Gabuzda, et al. CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation Blood, September 1, 2003; 102(5): 1745 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. A. MacDonald, D. J. Munster, G. J. Clark, A. Dzionek, J. Schmitz, and D. N. J. Hart Characterization of human blood dendritic cell subsets Blood, December 15, 2002; 100(13): 4512 - 4520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Osugi, S. Vuckovic, and D. N. J. Hart Myeloid blood CD11c+ dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes Blood, September 26, 2002; 100(8): 2858 - 2866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Y. Poluektova, D. H. Munn, Y. Persidsky, and H. E. Gendelman Generation of Cytotoxic T Cells Against Virus-Infected Human Brain Macrophages in a Murine Model of HIV-1 Encephalitis J. Immunol., April 15, 2002; 168(8): 3941 - 3949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. K. Ho, D. Munster, C. M. Pyke, D. N. J. Hart, and J. A. Lopez Spontaneous generation and survival of blood dendritic cells in mononuclear cell culture without exogenous cytokines Blood, April 15, 2002; 99(8): 2897 - 2904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Figueiredo, S. M. Nicholls, and D. L. Easty Corneal Epithelial Rejection in the Rat Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 729 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sanchez-Torres, G. S. Garcia-Romo, M. A. Cornejo-Cortes, A. Rivas-Carvalho, and G. Sanchez-Schmitz CD16+ and CD16- human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells Int. Immunol., December 1, 2001; 13(12): 1571 - 1581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Parlato, S. M. Santini, C. Lapenta, T. Di Pucchio, M. Logozzi, M. Spada, A. M. Giammarioli, W. Malorni, S. Fais, and F. Belardelli Expression of CCR-7, MIP-3beta , and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities Blood, November 15, 2001; 98(10): 3022 - 3029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O. Muench and A. Barcena Broad Distribution of Colony-Forming Cells with Erythroid, Myeloid, Dendritic Cell, and NK Cell Potential Among CD34++ Fetal Liver Cells J. Immunol., November 1, 2001; 167(9): 4902 - 4909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Schultz, J. Weiss, S. F. Carroll, and W. L. Gross The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies J. Leukoc. Biol., April 1, 2001; 69(4): 505 - 512. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
